Antimicrobial Chemotherapy Conference 2019
London, UK
Organized by the British Society for Antimicrobial Chemotherapy in collaboration with GARDP, the theme of the Antimicrobial Chemotherapy Conference 2019 is “An ABC for everyone involved in developing new antimicrobials”.
Opening remarks
Time: 9:30
| Laura Piddock, Head of Scientific Affairs, GARDP |
Session
Tackling Beta-lactamase mediated resistance
Time: 13:30-14:30
Chair:Laura Piddock, Head of Scientific Affairs, GARDP
| Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinations Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology, University of Liverpool |
| Metallobetalactamases and development of new compounds Martin Everett, Chief Scientific Officer, Antabio |
| Invited paper – REVIVE – a programme to support and connect the antimicrobial R&D community Astrid Pentz-Murr, Community manager REVIVE, GARDP |
The way forward: Clinical trial design and new drug development
Time: 14:35-16:00
Chair:William Hope, Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool
| Stimulating Antibiotic R&D through links to sustainable use and novel economic incentives Ursula Theuretzbacher, Founder, Center for Anti-Infective Agents |
| Developing a new drug for STIs Emilie Alirol, Project Leader, Sexually Transmitted Infections, GARDP |
| Innovative clinical trial design for unmet clinical needs: neonatal sepsis Julia Bielicki, Consultant in Paediatric Infectious Diseases, Lead Physician Infection Prevention and Control University of Basel Children’s Hospital |
| Clinical Trial Design for new antimicrobials: adults Aaron Dane, Director, DaneStat Consulting Limited |